RelieVR REF: RVX-2002 — Class II medical device recall Z-2044-2023
Completed recall by Appliedvr, reported 2023-07-05, distributed in NY. There is the potential for the program software to malfunction which will not allow it to move forward to the
| Recall number | Z-2044-2023 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Appliedvr, Van Nuys, CA, United States |
| Recall initiated | 2023-02-27 |
| Classified | 2023-06-29 |
| Reported by FDA | 2023-07-05 |
| Distributed | NY |
| Quantity | 1 units |
| Reason classes | device malfunction, software |
| Serial numbers | PA7940RGG5130514B |
| Model numbers | RVX-2002 |
Product
RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief.
Reason for recall
There is the potential for the program software to malfunction which will not allow it to move forward to the next session.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2044-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.